Published on in Vol 1, No 1 (2020): Inaugural Issue

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19371, first published .
Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation

Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation

Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation

Sukrit Srivastava   1, 2 , PhD ;   Sonia Verma   3 , MSc ;   Mohit Kamthania   4 , PhD ;   Rupinder Kaur   5 , PhD ;   Ruchi Kiran Badyal   6 , MPhil ;   Ajay Kumar Saxena   2 , PhD ;   Ho-Joon Shin   7 , PhD ;   Michael Kolbe   8, 9 , PhD ;   Kailash C Pandey   3 , PhD

1 Infection Biology Group, Department of Biotechnology, Mangalayatan University, Aligarh, India

2 Molecular Medicine Laboratory, School of Life Science, Jawaharlal Nehru University, New Delhi, India

3 Parasite-Host Biology Group, Protein Biochemistry and Engineering Lab, ICMR-National Institute of Malaria Research, New Delhi, India

4 Department of Biotechnology, Institute of Applied Medicines and Research, Ghaziabad, India

5 Department of Chemistry, Guru Nanak Dev University, Amritsar, India

6 Department of Economics, Mangalayata University, Aligarh, India

7 Department of Microbiology, School of Medicine, Ajou University, Suwon, Gyeonggi-do, Republic of Korea

8 Centre for Structural Systems Biology, Department for Structural Infection Biology, Helmholtz-Centre for Infection Research, Hamburg, Germany

9 Faculty of Mathematics, Informatics and Natural Sciences, University of Hamburg, Hamburg, Germany

Corresponding Author:

  • Sukrit Srivastava, PhD
  • Infection Biology Group
  • Department of Biotechnology
  • Mangalayatan University
  • Aligarh-Mathura Highway
  • Aligarh, 202145
  • India
  • Phone: 91 8178718421
  • Email: srivastav.sukrit@gmail.com